36C24E26Q0072_2.docx

DOCX document 27 KB Posted

Attached to
AN11--Degenerative cervical myelopathy (DCM) multi-omics services
Solicitation number
36C24E26Q0072
Issued by

About this file

This is an Amendment to a Request for Quote (RFQ) providing clarifications through Questions and Answers for solicitation 36C24E26Q0072. The Veterans Health Administration Regional Procurement Office East issued this combined synopsis/solicitation as a 100% small business set-aside for multi-omics services supporting a Degenerative Cervical Myelopathy (DCM) study at VA Pittsburgh Healthcare System. The requirement involves analysis services for 40 subject samples, with responses due by July 31, 2026, at 11:59 AM Eastern Time, submitted electronically to Contracting Officer Ms. Millicent Covert at millicent.covert@va.gov.

The amendment clarifies three critical technical specifications: (1) RNA-seq requires 6Gb sequencing depth or 150 million reads per sample; (2) sample collection involves three specialized tubes per subject totaling 120 tubes (40 PAXgene blood tubes for RNA analysis, 40 metabolomics plasma samples, and 40 proteomics plasma samples), with pre-collection separation required rather than post-collection splitting; and (3) proteomics analysis must utilize DIA-based LC-MS/MS technology, not Olink antibody-based panels, clarifying a discrepancy between pricing tables and scope narratives. The NAICS code 541380 (Testing Laboratories and Services) applies with a $19.0M small business employee size standard. This is a firm-fixed price contract awarded under FAR Subpart 12.6 for commercial items. The PSC is AN11 (Health R&D Services; Health Care Services; Basic Research). Quotes must comply with all instructions in the original solicitation and include completed Blocks 15A-15C of the SF30 Amendment form; incomplete submissions will be deemed non-responsive.

View the file

Other files

File Type Posted
RFQ 36C24E26Q0072 0001_ Amendment SF30.pdf PDF
36C24E26Q0072_1.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

SUBJECT*

Degenerative cervical myelopathy (DCM) multi-omics services

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
15215-1802
SOLICITATION NUMBER*
36C24E26Q0072
RESPONSE DATE/TIME/ZONE
07-31-2026 11:59 EASTERN TIME, NEW YORK, USA
ARCHIVE
30 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
SET-ASIDE
SBA
PRODUCT SERVICE CODE*
AN11
NAICS CODE*
541380
CONTRACTING OFFICE ADDRESS
Veterans Health Administration

Regional Procurement Office East Building 32 Suite 1A1111 1010 Delafield Road Pittsburgh PA 15215-1802

POINT OF CONTACT*

Contracting Officer Ms. Millicent Covert millicent.covert@va.gov (Calls shall not be accepted)

PLACE OF PERFORMANCE

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

Amendment to a Previous Combined Solicitation Amendment to a Previous Combined Solicitation

DESCRIPTION

*= Required Field
Amendment to a Previous Combined Solicitation

Page 1 of

Amendment to a Previous Combined Solicitation

AMENDMENT FOR SOLICITATION 36C24E26Q0072

This solicitation is being amended to provide Question and Answers to all offerers/bidders.

QUESTION and ANSWERS Q1: What sequencing depth (Gb) or number of reads per sample (M) is required for the RNA-seq component? If there is no specific target, may we recommend one?

A1: 6Gb, 150 million reads

Q2: What volume of plasma and whole blood will be provided per sample type? Additionally, will 40 separate samples be aliquoted for each project (i.e., dedicated plasma tubes for proteomics and for metabolomics), or will the same plasma sample be sent for both and need to be split at the facility?

A2: Blood will be collected in specialized tubes (one tube is specialized for proteomics and one for metabolomics) – they cannot be collected as one, and then later separated. Each subject will be given three tubes each: PAXgene blood tube will be mailed intact (zero processing), metabolomics blood sample will be centrifuged to collect plasma and placed into its dedicated Eppendorf tube and metabolomics blood sample will be centrifuged to collect plasma and placed into its dedicated Eppendorf tube. There will be 40 subjects for a total of 120 tubes (40 intact blood tubes for RNA, 40 metabolomics plasma samples, and 40 proteomics samples).

Q3: The pricing table (Item 0002) specifies DIA-based LC-MS/MS proteomics, but the Scope/Task 2 narrative specifies "Olink proteomics analysis." These are different technologies (untargeted mass spec vs. targeted antibody-based panels) requiring different vendor capabilities and pricing. Please confirm which platform is required—DIA-MS, Olink, or both. If Olink is required, please specify the panel (e.g., Olink Explore HT, Target 96 Inflammation, etc.).

A3: Thank you for pointing out the discrepancy. DIA-base proteomics is the platform required.

Extension for offers is not granted. Submission deadline remains as no later than Friday, July 31, 2026, at 11:59AM Eastern Time.

IMPORTANT: complete all instructions as noted in “Instructions to Offeror” within original solicitation. Additionally, please complete Blocks 15A – 15C AMENDMENT OF SOLICITATION document. Incomplete submissions will be considered non-responsive.

All offeror quotes for this solicitation must be received electronically through email no later than Friday, July 31, 2026, at 11:59AM Eastern Time. Offers shall be sent by email to Millicent Covert at millicent.covert@va.gov. Reference solicitation number 36C24E26Q0072 within subject line of the email. Any quotes received after the prescribed date/time shall be considered non-responsive and will not be considered for award.

See attached document: RFQ 36C24E26Q0072 0001_ Amendment SF30.

File details come from the government source that posted it. Updated .